Gout, which is characterized by deposition of monosodium urate monohydrate (MSU) in synovial fluid and other tissues, is the most common form of inflammatory arthritis.
Gout Classification Criteria
|Step 1: Entry criterion (only apply criteria below to those meeting this entry criterion)||At least 1 episode of swelling, pain, or tenderness in a peripheral joint or bursa|
|Step 2: Sufficient criterion (if met, can classify as gout without applying criteria below)||Presence of MSU crystals in a symptomatic joint or bursa (i.e., in synovial fluid) or tophus|
|Step 3: Criteria (to be used if sufficient criterion not met)|
|Pattern of joint/bursa involvement during symptomatic episode(s) ever†||Ankle or midfoot (as part of monoarticular or oligoarticular episode without involvement of the first metatarsophalangeal joint||1|
|Involvement of the first metatarsophalangeal joint (as part of monoarticular or oligoarticular episode)||2|
|Characteristics of symptomatic episode(s) ever
|Time course of episode(s) ever
Presence (ever) of ≥2, irrespective of antiinflammatory treatment:
|One typical episode||1|
|Recurrent typical episodes||2|
|Clinical evidence of tophus
Draining or chalk-like subcutaneous nodule under transparent skin, often with overlying vascularity, located in typical locations: joints, ears, olecranon bursae, finger pads, tendons (e.g., Achilles)
|Serum urate: Measured by uricase method. Ideally should be scored at a time when the patient was not receiving urate-lowering treatment and it was >4 weeks from the start of an episode (i.e., during intercritical period); if practicable, retest under those conditions. The highest value irrespective of timing should be scored.||<4 mg/dl (<0.24 mmoles/liter)‡||-4|
|6–8 mg/dl (0.36–<0.48 mmoles/liter)||2|
|8–<10 mg/dl (0.48–<0.60 mmoles/liter)||3|
|≥10 mg/dl (≥0.60 mmoles/liter)||4|
|Synovial fluid analysis of a symptomatic (ever) joint or bursa (should be assessed by a trained observer)§||MSU negative||-2|
|Imaging evidence of urate deposition in symptomatic (ever) joint or bursa: ultrasound evidence of double-contour sign# or DECT demonstrating urate deposition**||Present (either modality)||4|
|Imaging evidence of gout-related joint damage: conventional radiography of the hands and/or feet demonstrates at least 1 erosion††||Present||4|
† Symptomatic episodes are periods of symptoms that include any swelling, pain, and/or tenderness in a peripheral joint or bursa.
‡ If serum urate level is <4 mg/dl (<0.24 mmoles/liter), subtract 4 points; if serum urate level is ≥4-<6 mg/dl (≥0.24-<0.36 mmoles/liter), score this item as 0.
§ If polarizing microscopy of synovial fluid from a symptomatic (ever) joint or bursa by a trained examiner fails to show monosodium urate monohydrate (MSU) crystals, subtract 2 points. If synovial fluid was not assessed, score this item as 0.
¶ If imaging is not available, score these items as 0.
# Hyperechoic irregular enhancement over the surface of the hyaline cartilage that is independent of the insonation angle of the ultrasound beam (note: false-positive double-contour sign [artifact] may appear at the cartilage surface but should disappear with a change in the insonation angle of the probe).
** Presence of color-coded urate at articular or periarticular sites. Images should be acquired using a dual-energy computed tomography (DECT) scanner, with data acquired at 80 kV and 140 kV and analyzed using gout-specific software with a 2-material decomposition algorithm that color-codes urate. A positive scan is defined as the presence of color-coded urate at articular or periarticular sites. Nailbed, submillimeter, skin, motion, beam hardening, and vascular artifacts should not be interpreted as DECT evidence of urate deposition.
†† Erosion is defined as a cortical break with sclerotic margin and overhanging edge, excluding distal interphalangeal joints and gull wing appearance.
- Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJ, Lioté F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F, Saag K, Singh JA, Sundy JS, Tausche AK, Vazquez-Mellado J, Yarows SA, Taylor WJ. 2015 Gout Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheumatol. 2015 Oct;67(10):2557-68. [Medline]
- Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJ, Lioté F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F, Saag K, Singh JA, Sundy JS, Tausche AK, Vaquez-Mellado J, Yarows SA, Taylor WJ. 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2015 Oct;74(10):1789-98. [Medline]
Created Jul 23, 2018.